These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23211241)

  • 1. Possible increased potency of current levothyroxine.
    Khan M; Halpin R
    Br J Gen Pract; 2012 Dec; 62(605):628-9. PubMed ID: 23211241
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels.
    Brito JP; Ross JS; Sangaralingham L; Dutcher SK; Graham DJ; Wang Z; Wu Y; Yao X; Smallridge RC; Bernet V; Shah ND; Lipska KJ
    JAMA Netw Open; 2020 Sep; 3(9):e2017645. PubMed ID: 32997127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyroxine-binding proteins--familial euthyroid hyperthyroxinemia due to point mutations of transthyretin].
    Hishinuma A; Mochizuki Y; Kasai K; Shimoda S
    Nihon Rinsho; 1994 Apr; 52(4):886-9. PubMed ID: 8196175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euthyroid hyperthyroxinaemia due to endogenous antibodies to thyroxine and tri-iodothyronine. A case report.
    Mulligan GP; Davidson JS; Kaplan H; Abrahamson MJ
    S Afr Med J; 1989 Feb; 75(4):181-3. PubMed ID: 2919341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthyroxinemia in patients receiving thyroid replacement therapy.
    Grund FM; Niewoehner CB
    Arch Intern Med; 1989 Apr; 149(4):921-4. PubMed ID: 2705841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient prealbumin-associated hyperthyroxinemia in TSH-producing pituitary adenoma.
    Lind P; Langsteger W; Költringer P; Wakonig P; Eber B; Mokry M; Beham A; Eber O
    Nuklearmedizin; 1990 Feb; 29(1):40-3. PubMed ID: 2108434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Euthyroid hyperthyroxinemia].
    Hayashi Y
    Nihon Rinsho; 2006 May; Suppl 1():533-5. PubMed ID: 16776208
    [No Abstract]   [Full Text] [Related]  

  • 9. Etiology and outcome of non-estrogen associated hyperthyroxinemia in euthyroid patients at the San Juan City Hospital.
    Alegre M; Meléndez EG; Colón G
    Bol Asoc Med P R; 1996; 88(1-3):12-5. PubMed ID: 8885441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient hyperthyroxinemia associated with rickets.
    Leung AK
    J Natl Med Assoc; 1988 May; 80(5):590-3. PubMed ID: 3418738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial non-toxic hyperthyroxinaemia: receptor or 5'-deiodinase defect or deficiency.
    Crothers DC; Harvey TC; Faber J; Ramsden DB
    Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():109-14. PubMed ID: 1536517
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis.
    Hepp Z; Wyne K; Manthena SR; Wang S; Gossain V
    Curr Med Res Opin; 2018 Sep; 34(9):1673-1678. PubMed ID: 29874941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider and Patient Determinants of Generic Levothyroxine Prescribing: An Electronic Health Records-Based Study.
    Romanelli RJ; Nimbal V; Dutcher SK; Pu X; Segal JB
    Ann Pharmacother; 2017 Aug; 51(8):640-648. PubMed ID: 28425295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in thyroid tests in non-thyroid diseases].
    Ghayad E; Choueiri Medlej R
    J Med Liban; 1996; 44(1):31-5. PubMed ID: 8965317
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperthyroxinemia and elevated lipids as paraneoplastic phenomena in hepatocellular carcinoma. A case report.
    Nizam R; Ahmed F
    J Clin Gastroenterol; 1995 Oct; 21(3):246-8. PubMed ID: 8648063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothyroidism resulting from generic levothyroxine failure.
    Dong BJ; Brown CH
    J Am Board Fam Pract; 1991; 4(3):167-70. PubMed ID: 2053456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of generic budeprion for nonbioequivalence.
    Woodcock J; Khan M; Yu LX
    N Engl J Med; 2012 Dec; 367(26):2463-5. PubMed ID: 23216549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Unusual etiology of free hyperthyroxinemia].
    Gernez-Lestradet C; Mollet E; Chatelain F; Massol J
    Arch Fr Pediatr; 1987 Mar; 44(3):231-2. PubMed ID: 3579488
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic levothyroxine.
    Med Lett Drugs Ther; 2004 Sep; 46(1192):77-8. PubMed ID: 15452463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.